The analysis notes that drug resistance is becoming more of an issue across the entire infection control continuum. Patients, third party payers and tax payers, through Medicare and Medicaid payments, shoulder the added expense of hospital infections, which is an estimated $35 billion to $40 billion in costs each year in the U.S.
The U.S. provided more than $11 million in state funding for HAI prevention infrastructure projects and development in 2013, according to the report.
More articles on quality:
Study: Bloodstream infection-causing bacteria increasingly resistant to common antiseptic
Hand hygiene or environmental cleaning: Which is more effective?
Research identifies predictors of COPD patient early readmission
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.